Edwards Lifesciences Corp (EW) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-17 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Zovighian Bernard J CIK: 0001665141 Role: Director, Officer (CEO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-17 | Code: S (Open market sale) Shares: -523 | Price: $87.92 Total Value: $45,982.16 Shares Owned After: 11,516.5511 | Ownership: I (Indirect) | Nature: By Trust Footnotes: [F1] The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. --- Holdings --- [Holding #1] Security: Common Stock Ownership: D (Direct) [Holding #2] Security: Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-06-17)